Evidence map›Paper›PMID 31781612›Full record

ArticleBioMed research international2019

Saad Abdulrahman Hussain, Hazha Abdulah Mohammed Ameen, Mohammed Omer Mohammed, Khadija Muhamed Ahmed, Rebaz Hama-Gareb Ali, Banaz Mubarak Safar, Kamal Ahmed Saeed

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Symptom dynamics through multiphase treatment in acute myeloid leukemia: a cross-lagged panel network analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Saad Abdulrahman HussainDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Rafidain University College, Baghdad, Iraq.ORCID https://orcid.org/0000-0002-1909-417X
Hazha Abdulah Mohammed AmeenDepartment of Medicine, College of Medicine, University of Sulaimani, Kurdistan Region, Sulaimani, Iraq.
Mohammed Omer MohammedDepartment of Medicine, College of Medicine, University of Sulaimani, Kurdistan Region, Sulaimani, Iraq.
Khadija Muhamed AhmedDepartment of Oral Pathology, College of Dentistry, University of Sulaimani, Kurdistan Region, Sulaimani, Iraq.
Rebaz Hama-Gareb AliDepartment of Pharmaceutics, College of Pharmacy, University of Sulaimani, Kurdistan Region, Sulaimani, Iraq.
Banaz Mubarak SafarHiwa Oncology Hospital, Sulaimani, Kurdistan Region, Iraq.
Kamal Ahmed SaeedDepartment of Surgery, College of Medicine, University of Sulaimani, Kurdistan Region, Sulaimani, Iraq.
University of Sulaimani · IQAlrafidain University College · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe present study aims at evaluating the beneficial effect of

methodsFifty-four AML patients were participated in this study and randomly allocated to either the test group or a control group. The patients of the test group received NS oil mouth rinse during 28-day CT, while the participants of the control group received a "magic mouthwash" formula. The primary outcome of this study was the incidence and severity of CT-induced OM in terms of erythema and ulcer. The secondary outcomes were the pain severity score, swallowing function, and the salivary concentrations of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-

resultsNS oil mouth rinse attenuated the progression of CT-induced OM compared with the control formula (AUC = 5.9 vs. 38.4,

conclusionsNS oil mouth rinse is effective in attenuating the severity of CT-induced OM and improves the pain and swallowing function in AML patients.

Indexed as

AdultFemaleGene Expression Regulation, NeoplasticHumansInterleukin-6Leukemia, Myeloid, AcuteMaleMiddle AgedMouthwashesNigella sativaPlant OilsStomatitisTumor Necrosis Factor-alphaInterleukin-6MouthwashesPlant OilsTumor Necrosis Factor-alpha

Identifiers

PMID31781612
PMCPMC6875195
OpenAlexW2982665373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.